These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15334305)

  • 1. Medicinal chemistry--29th National Symposium. Kinase inhibitors.
    Lackey K
    IDrugs; 2004 Aug; 7(8):732-5. PubMed ID: 15334305
    [No Abstract]   [Full Text] [Related]  

  • 2. American Chemical Society--229th National Meeting. Kinase modulators.
    Mackonochie M; Chan D
    IDrugs; 2005 Apr; 8(4):283-4. PubMed ID: 15800796
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug discovery process for kinase inhibitors.
    Weinmann H; Metternich R
    Chembiochem; 2005 Mar; 6(3):455-9. PubMed ID: 15742380
    [No Abstract]   [Full Text] [Related]  

  • 4. Medicinal Chemistry - XXth International Symposium. Lead finding strategies and kinase selectivity.
    Rotella DP
    IDrugs; 2008 Nov; 11(11):774-8. PubMed ID: 18988116
    [No Abstract]   [Full Text] [Related]  

  • 5. 19th International Symposium on Medicinal Chemistry.
    Baker M
    ACS Chem Biol; 2006 Oct; 1(9):549-53. PubMed ID: 17168546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinase inhibitors of marine origin.
    Bharate SB; Sawant SD; Singh PP; Vishwakarma RA
    Chem Rev; 2013 Aug; 113(8):6761-815. PubMed ID: 23679846
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicinal chemistry--29th National Symposium. SERMs and SARMs.
    Lackey K
    IDrugs; 2004 Aug; 7(8):729-31. PubMed ID: 15334304
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial:Shaping Current and Future Kinase Drug Discovery.
    Bhalla N
    Curr Top Med Chem; 2017; 17(22):2469. PubMed ID: 28799507
    [No Abstract]   [Full Text] [Related]  

  • 9. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts.
    Ma X; Lv X; Zhang J
    Eur J Med Chem; 2018 Jan; 143():449-463. PubMed ID: 29202407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule kinase-inhibitor target assessment.
    Kung C; Shokat KM
    Chembiochem; 2005 Mar; 6(3):523-6. PubMed ID: 15696508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early career research in medicinal chemistry.
    Baell JB
    Future Med Chem; 2021 Jan; 13(2):91-93. PubMed ID: 33487046
    [No Abstract]   [Full Text] [Related]  

  • 12. Recent developments in the discovery of protein kinase inhibitors from the urea class.
    Dumas J; Smith RA; Lowinger TB
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):600-16. PubMed ID: 15503863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.
    Bamborough P; Drewry D; Harper G; Smith GK; Schneider K
    J Med Chem; 2008 Dec; 51(24):7898-914. PubMed ID: 19035792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of inhibitors that bind to inactive kinase conformations.
    Liu Y; Gray NS
    Nat Chem Biol; 2006 Jul; 2(7):358-64. PubMed ID: 16783341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Turning promiscuous kinase inhibitors into safer drugs.
    Zhang X; Crespo A; Fernández A
    Trends Biotechnol; 2008 Jun; 26(6):295-301. PubMed ID: 18403035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-Molecule Kinase Downregulators.
    Jones LH
    Cell Chem Biol; 2018 Jan; 25(1):30-35. PubMed ID: 29174540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design strategies for protein kinase inhibitors.
    Parang K; Sun G
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):617-29. PubMed ID: 15503864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge-based design of 7-azaindoles as selective B-Raf inhibitors.
    Tang J; Hamajima T; Nakano M; Sato H; Dickerson SH; Lackey KE
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4610-4. PubMed ID: 18662874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advancing the kinase field: new targets and second generation inhibitors.
    Laufer S; Bajorath J
    J Med Chem; 2015 Jan; 58(1):1. PubMed ID: 25490234
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeting the DFG-in kinase conformation: a new trend emerging from a patent analysis.
    Angiolini M
    Future Med Chem; 2011 Mar; 3(3):309-37. PubMed ID: 21446845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.